FDA Releases Draft Guidance on Xenotransplantation Blood Product Safety

Summary

The Food and Drug Administration (FDA) has released a draft document outlining precautionary measures to reduce the risk of zoonoses transmission through blood and blood products from xenotransplantation recipients and their contacts, following revisions based on public comments.